Low income vs Switzerland: Access to anti-retroviral drugs, male
Low income
79.4%
in 2024
Switzerland
90.0%
in 2023
Low income rank
10th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Low income
- Switzerland
How they compare
Switzerland currently reports 90.0% against 79.4% in Low income, a difference of 10.6%.
That makes Switzerland's figure about 1.1 times Low income's.
Across all 24 years both countries report, Switzerland has been ahead every year.
Low income ranks 10th and Switzerland ranks 13th of 19 groups.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Low income | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 50.0% | 44.7% | Switzerland |
| 2010s | 38.8% | 79.2% | 40.4% | Switzerland |
| 2020s | 69.5% | 90.2% | 20.7% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Low income or Switzerland?
- Switzerland, at 90.0% against 79.4% in Low income as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Low income and Switzerland?
- 10.6%, with Switzerland ahead.
- How many years of comparable data are there for Low income and Switzerland?
- 24 years are reported by both, from 2000 to 2023.
- How do Low income and Switzerland rank globally for access to anti-retroviral drugs, male?
- Low income ranks 10th and Switzerland ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.